Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.
Dickson MA, D'Adamo DR, Keohan ML, D'Angelo SP, Carvajal RD, Gounder MM, Maki RG, Qin LX, Lefkowitz RA, McKennon OR, Hirst CM, Schwartz GK, Tap WD.
Dickson MA, et al. Among authors: hirst cm.
Sarcoma. 2015;2015:532478. doi: 10.1155/2015/532478. Epub 2015 May 14.
Sarcoma. 2015.
PMID: 26074722
Free PMC article.